EARLY INTERIM FDG-PET DURING INTESIFIED BEACOPP THERAPY FOR ADVANCED-STAGE HODGKIN DISEASE SHOWS A LOWER POSITIVE PREDICTIVE VALUE THAN DURING ABVD

被引：0
|
作者：
Fiore, F. [1 ]
Viviani, S. [2 ]
Luminari, S. [3 ]
Levis, A. [4 ]
Di Raimondo, F. [5 ]
Merli, F. [6 ]
Vitolo, U. [7 ]
Bolis, S. [8 ]
Federico, M. [8 ]
Gallamini, A. [1 ]
机构：
[1] Az Osped S Croce & Carle Cuneo, Dept Hematol, Cuneo, CN, Italy
[2] Ist Nazl Tumori Milano, Dept Med Oncol, Milan, Italy
[3] Univ Modena & Reggio Emilia, Dept Haematol & Oncol, Modena, Italy
[4] Az Osped S Antonio & Biagio, Dept Hematol, Alessandria, Italy
[5] Univ Catania, Hematol Chair, Catania, Italy
[6] Arcispedale S Maria Nuova, Dept Hematol, Reggio Emilia, Italy
[7] Az Osped S Giovanni Battista, Dept Hematol, Turin, Italy
[8] Osped San Gerardo, Dept Hematol, Monza, Italy
来源：
HAEMATOLOGICA | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
C061
引用
收藏
页码：S18 / S18
页数：1
相关论文
共 50 条
  • [41] THE LONG-TERM OUTCOME OF PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA AND NEGATIVE INTERIM PET FAILING ABVD MIGHT BE WORSE THAN THAT OF INTERIM PET POSITIVE PATIENTS UNDERGOING EARLY TREATMENT INTENSIFICATION WITH ESCALATED BEACOPP
    Zaucha, J. M.
    Malkowski, B.
    Subocz, E.
    Tajer, J.
    Kulikowski, W.
    Panebianco, M.
    Grad, J.
    Rybka, J.
    Kroll-Balcerzak, R.
    Romanowicz, A.
    Chamier-Cieminska, A.
    Kurczab, P.
    Cimino, G.
    Chauvie, S.
    Knopinska-Posluszny, W.
    Walewski, J.
    Gallamini, A.
    HAEMATOLOGICA, 2016, 101 : 53 - 54
  • [42] The prognostic value of the tumor/microenvironment signature compared to early pet scan in advanced-stage, ABVD-treated Hodgkin lymphoma patients
    Gallamini, A.
    Agostinelli, C.
    Rigacci, L.
    D'Amore, F.
    Merli, F.
    Zinzani, P.
    Vitolo, U.
    Patti, C.
    Stelitano, C.
    Di Raimondo, F.
    Levis, A.
    Trentin, L.
    Chisesi, T.
    Kamper, P.
    Pileri, S.
    ANNALS OF ONCOLOGY, 2008, 19 : 125 - 125
  • [43] eAssessment of Early Treatment Response after 4 Cycles of Chemotherapy using FDG-PET in Patients with Advanced-Stage Hodgkin Lymphoma
    Kobe, C.
    Markova, J.
    Skopalova, M.
    Klaskova, K.
    Dedeckova, K.
    Pluetschow, A.
    Eich, H. T.
    Dietlein, M.
    Engert, A.
    Kozak, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 (SUPPL 2) : 252 - 253
  • [44] Assessment of Early Treatment Response after 4 Cycles of Chemotherapy using FDG-PET in Patients with Advanced-Stage Hodgkin Lymphoma
    Kobe, C.
    Markova, J.
    Skopalova, M.
    Klaskova, K.
    Dedeckova, K.
    Pluetschow, A.
    Eich, H. T.
    Dietlein, M.
    Engert, A.
    Kozak, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S252 - S253
  • [45] FDG-PET for assessment of early therapy response after 4 cycles of chemotherapy in advanced stage Hodgkin lymphoma
    Markova, J.
    Skopalova, M.
    Kobe, C.
    Klaskova, K.
    Zikavska, L.
    Polivka, J.
    Vernerova, Z.
    Kamaradova, K.
    Dedeckova, K.
    Kozak, T.
    ANNALS OF ONCOLOGY, 2008, 19 : 135 - 135
  • [46] Interim analysis of the HD9 study of the German Hodgkin study group (GHSG) - BEACOPP is more effective than COPP-ABVD in advanced stage Hodgkin's disease.
    Diehl, V
    Lathan, B
    Engert, A
    Franklin, J
    Ruffer, U
    Sieber, M
    Wolf, J
    Pfreundschuh, M
    Koch, P
    Adler, M
    Muller, U
    Schalk, P
    Dolken, G
    Worst, P
    Boissevain, F
    Loffler, M
    Tesch, H
    BLOOD, 1997, 90 (10) : 1512 - 1512
  • [47] Response-adapted therapy using FDG-PET after BEACOPP-chemotherapy in advanced stage Hodgkin's lymphoma - An interim analysis of the German Hodgkin Study Group (GHSG) trial HD15
    Eich, H. T.
    Kobe, C.
    Dietlein, M.
    Engert, A.
    Kriz, J.
    Mueller, R. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S471 - S471
  • [48] Does interim 18F-FDG-PET response-adapted therapy really benefit advanced-stage Hodgkin lymphoma patients?
    Adams, Hugo J. A.
    Kwee, Thomas C.
    NUCLEAR MEDICINE COMMUNICATIONS, 2016, 37 (12) : 1333 - 1334
  • [49] Predicitive value of early FDG PET during salvage chemotherapy in relapsing and refractory Hodgkin's disease
    Castagna, L.
    Bramanti, S.
    Balzarotti, M.
    Rodari, M.
    Sarina, B.
    Todisco, E.
    Anastasia, A.
    Santoro, A.
    Chiti, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S291 - S292
  • [50] Predictive value of 18FDG-PET scan performed after two courses of standard therapy on treatment outcome in advanced-stage Hodkin's disease
    Gallamini, A.
    Tavera, S.
    Biggi, A.
    Torchio, F.
    Rigacci, L.
    Castagnoli, A.
    Merli, F.
    Versari, A.
    Luminari, S.
    Chisesi, T.
    Gregianin, M.
    Vitolo, U.
    Pelosi, E.
    Iannitto, E.
    Levis, A.
    ANNALS OF ONCOLOGY, 2005, 16 : 7 - 7
12345